Kh. Lu et al., EVIDENCE FOR THE MULTIFOCAL ORIGIN OF BILATERAL AND ADVANCED HUMAN SEROUS BORDERLINE OVARIAN-TUMORS, Cancer research, 58(11), 1998, pp. 2328-2330
Borderline ovarian turners (BOTs), or ovarian tumors of low malignant
potential, represent a distinct category of epithelial ovarian neoplas
ms that have a clinically more favorable outcome than invasive epithel
ial ovarian cancer. Histologically, BOTs and invasive ovarian carcinom
as both show cellular proliferation and pleomorphism, but unlike invas
ive ovarian carcinomas, BOTs lack stromal invasion. Although serous BO
TS are frequently confined to a single ovary at the time of diagnosis,
bilateral or extra-ovarian spread occurs in 30-40% of cases, The purp
ose of this study is to determine whether bilateral or extraovarian se
rous borderline lesions are metastatic sites from the original tumor,
or represent separate primary tumors, DNA specimens from multiple tumo
r sites and normal tissue controls were obtained in eight women with b
ilateral or extra-ovarian serous borderline turners. The pattern of lo
ss of heterozygosity at the androgen receptor locus on the X chromosom
e was evaluated in the multiple tumor sites. Tn addition, the pattern
of X-chromosome inactivation was determined using HpaII restriction en
donuclease digestion, followed by PCR amplification of the androgen re
ceptor locus, Multifocality, was determined when alternate patterns of
X-chromosome inactivation occurred, In two of the eight patients, the
left and right ovarian tumor sites had different androgen receptor al
leles inactivated, indicating that the bilateral tumors derived indepe
ndently. In a third patient, the TF, inactivation pattern in the left
ovarian tumor differed from the two peritoneal implants, suggesting th
at the implants were separate primary tumors, and not metastatic, from
the left ovarian tumor, The remaining five patients had the same patt
ern of loss of heterozygosity and X inactivation in the tumor sites st
udied, These results suggest that bilateral and advanced stage serous
BOTs may be multifocal in origin, This result is in contrast to invasi
ve epithelial ovarian cancer, which has been shown to be unifocal in o
rigin.